Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.42 |
| ▸ | GHSR | Q92847 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | LIPE | Q05469 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31566040 | 0.88 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31566054 | 0.88 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31566066 | 0.87 | GHSR (0.49) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31565905 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31565927 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31565916 | 0.85 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31565855 | 0.85 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1SCN9AGHSRESR1 | |
| SCHEMBL31566016 | 0.84 | ESR1 (0.47) | SCN9AGHSRESR1ESR2HRH3 | |
| SCHEMBL31565889 | 0.84 | ESR1 (0.47) | ALDH1A1L3MBTL1GHSRESR1ESR2 | |
| SCHEMBL31566079 | 0.84 | KDM4E (0.44) | ALDH1A1L3MBTL1GHSRESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129028-A1 | COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR | Opna Bio SA (CH) | 2025-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129028-A1 | COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR | YAP1, YES1, LATS1 | ALDH1A1 2760/4885L3MBTL1 1076/4885SCN9A 1683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.